From protocol development and submission through end-of-study reporting, we partner with you to build smarter trials that meet regulatory expectations and move therapeutic progress forward
Topical KPV and PEPITEM-derived tripeptides have been studied for direct application to affected skin
GLP-1s are shaping how people eat, drink, shop, and exercise, and brands need to be paying close attention to these trends. Also referencing the KFF survey, Shil Kothari, president at Gateway Health Alliances Inc., Fairfield, Calif., explains that the awareness of GLP-1s mean that beverage manufacturers must play a proactive role in offering solutions that support those using these medications
Greater weight loss during treatment was associated with greater rebound, suggesting biological adaptations, potentially involving changes in appetite hormones, metabolism, or reward sensitivitythat increase susceptibility to weight regain [141]